Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?
暂无分享,去创建一个
A D Paltiel | D J Hunter | R. Walensky | J. Jordan | J. Katz | L. Suter | E. Losina | D. Solomon | D. Hunter | S. Burbine | A. Paltiel | M. E. Daigle | E Losina | M E Daigle | L G Suter | D H Solomon | R P Walensky | J M Jordan | S A Burbine | J N Katz | J. Katz | Meghan E. Daigle
[1] Gheorghe Luta,et al. Prevalence of knee symptoms and radiographic and symptomatic knee osteoarthritis in African Americans and Caucasians: the Johnston County Osteoarthritis Project. , 2007, The Journal of rheumatology.
[2] T. Spector,et al. Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial , 2012, Annals of the rheumatic diseases.
[3] Lisa I. Iezzoni,et al. Risk Adjustment of Medicare Capitation Payments Using the CMS-HCC Model , 2004, Health care financing review.
[4] J. Raynauld,et al. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. , 2003, Arthritis and rheumatism.
[5] L. Kazis,et al. The Association of Bone Marrow Lesions with Pain in Knee Osteoarthritis , 2001, Annals of Internal Medicine.
[6] M. Roberts,et al. What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule? , 2008, Medical care.
[7] Rob Baltussen,et al. Making Choices in Health: WHO Guide to Cost Effectiveness Analysis , 2003 .
[8] David Felson,et al. Association between radiographic features of knee osteoarthritis and pain: results from two cohort studies , 2009, BMJ : British Medical Journal.
[9] P Tugwell,et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. , 2008, Osteoarthritis and cartilage.
[10] J. Jansen,et al. Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of ankylosing spondylitis in the UK , 2007, Current medical research and opinion.
[11] A David Paltiel,et al. Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume. , 2009, Archives of internal medicine.
[12] Sally C. York,et al. Long-term follow-up care recommendations after total hip and knee arthroplasty: results of the American Association of Hip and Knee Surgeons' member survey. , 2003, The Journal of arthroplasty.
[13] Gordon Guyatt,et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee , 2012, Arthritis care & research.
[14] J. Kopec,et al. After patients are diagnosed with knee osteoarthritis, what do they do? , 2010, Arthritis care & research.
[15] S. Gabriel,et al. The cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[16] X. Ayral. Injections in the treatment of osteoarthritis. , 2001, Best practice & research. Clinical rheumatology.
[17] M. Feinleib. National Center for Health Statistics (NCHS) , 2005 .
[18] Rosalind J Wright,et al. Association between hospital and surgeon procedure volume and the outcomes of total knee replacement. , 2004, The Journal of bone and joint surgery. American volume.
[19] M. Buntin,et al. How Much is Post-Acute Care Use Affected by its Availability? , 2004, Health services research.
[20] Peter A Ubel,et al. What is the price of life and why doesn't it increase at the rate of inflation? , 2003, Archives of internal medicine.
[21] J. Brazier,et al. Deriving a preference-based single index from the UK SF-36 Health Survey. , 1998, Journal of clinical epidemiology.
[22] M. Buntin,et al. How Much is Post-Acute Care Use Affected by its Availability? , 2004, Health services research.
[23] M C Weinstein,et al. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.
[24] J. Jordan,et al. Determinants of self-reported health status in a population-based sample of persons with radiographic knee osteoarthritis. , 2009, Arthritis and rheumatism.
[25] P. Isakson,et al. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial. , 1999, Mayo Clinic proceedings.
[26] F. Silverstein,et al. Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor , 2000, American Journal of Gastroenterology.
[27] Rochelle P. Walensky,et al. Impact of Obesity and Knee Osteoarthritis on Morbidity and Mortality in Older Americans , 2011, Annals of Internal Medicine.
[28] S. Gabriel,et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. , 2008, Arthritis and rheumatism.
[29] J. Jordan,et al. Forecasting the burden of advanced knee osteoarthritis over a 10-year period in a cohort of 60-64 year-old US adults. , 2011, Osteoarthritis and cartilage.
[30] E. Roos,et al. High prevalence of osteoarthritis 14 years after an anterior cruciate ligament tear in male soccer players: a study of radiographic and patient relevant outcomes , 2004, Annals of the rheumatic diseases.
[31] David J. Hunter,et al. Pharmacologic therapy for osteoarthritis—the era of disease modification , 2011, Nature Reviews Rheumatology.
[32] J. Dekker,et al. Factors contributing to possession and use of walking aids among persons with rheumatoid arthritis and osteoarthritis. , 2003, Arthritis and rheumatism.
[33] R. Makuch,et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. , 2000, JAMA.
[34] J. Martin,et al. National Vital Statistics Reports , 2002 .
[35] Elizabeth W Paxton,et al. A prospective study of 80,000 total joint and 5000 anterior cruciate ligament reconstruction procedures in a community-based registry in the United States. , 2010, The Journal of bone and joint surgery. American volume.
[36] Elena Losina,et al. Association of hospital and surgeon procedure volume with patient-centered outcomes of total knee replacement in a population-based cohort of patients age 65 years and older. , 2007, Arthritis and rheumatism.
[37] Patrick W. Sullivan,et al. Preference-Based EQ-5D Index Scores for Chronic Conditions in the United States , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.
[38] M. Keith,et al. American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of osteoarthritis (OA) of the knee. , 2010, The Journal of bone and joint surgery. American volume.
[39] A. Woolf,et al. The long-term effects of non-steroidal anti-inflammatory drugs in osteoarthritis of the knee: a randomized placebo-controlled trial. , 2000, Rheumatology.
[40] M. Englund,et al. Risk factors for symptomatic knee osteoarthritis fifteen to twenty-two years after meniscectomy. , 2004, Arthritis and rheumatism.
[41] J. Spertus,et al. Transforming Self-Rated Health and the SF-36 Scales to Include Death and Improve Interpretability , 2001, Medical care.
[42] L. Sharma,et al. Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial. , 2005, Arthritis and rheumatism.
[43] A. Guermazi,et al. The reliability of a new scoring system for knee osteoarthritis MRI and the validity of bone marrow lesion assessment: BLOKS (Boston–Leeds Osteoarthritis Knee Score) , 2007, Annals of the rheumatic diseases.
[44] T. Spector,et al. Osteoarthritis: New Insights. Part 1: The Disease and Its Risk Factors , 2000, Annals of Internal Medicine.
[45] Atlanta,et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. , 2008, Arthritis and rheumatism.
[46] D. Hunter,et al. The epidemiology of osteoarthritis. , 2014, Best practice & research. Clinical rheumatology.
[47] Timothy E. McAlindon,et al. Osteoarthritis: New Insights , 2002 .
[48] Milton C. Weinstein,et al. Recommendations for Reporting Cost-effectiveness Analyses , 1996 .
[49] D. Felson,et al. Consistency of Knee Pain and Risk of Knee Replacement: The Multicenter Osteoarthritis Study , 2011, The Journal of Rheumatology.
[50] D J Hunter,et al. Responsiveness to change and reliability of measurement of radiographic joint space width in osteoarthritis of the knee: a systematic review. , 2011, Osteoarthritis and cartilage.
[51] S. Abramson,et al. Prospects for disease modification in osteoarthritis , 2006, Nature Clinical Practice Rheumatology.
[52] Scott D. Solomon,et al. Cardiovascular Risk Associated With Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention , 2005 .
[53] R. Shephard. Body-Mass Index and Mortality among 1.46 Million White Adults , 2011 .
[54] D. Feeny,et al. Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. , 1996, Medical care.
[55] B. Morrey. A Prospective Study of 80,000 Total Joint and 5000 Anterior Cruciate Ligament Reconstruction Procedures in a Community-Based Registry in the United States , 2011 .
[56] E. Arias,et al. United States life tables, 2006. , 2010, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[57] J. Senior,et al. Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs , 1995, Annals of Internal Medicine.
[58] J. Clouse,et al. Implications of controlling for comorbid conditions in cost-of-illness estimates: a case study of osteoarthritis from a managed care system perspective. , 2001, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[59] L. Sharma,et al. Is obesity a risk factor for progressive radiographic knee osteoarthritis? , 2009, Arthritis and rheumatism.